The leader in quality education and networking through//conferences, courses and custom training

AsiaTIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

2011年のイベントのまとめ

Keynote Presentations

Clinical Development of Mipomersen, an Antisense Second-Generation Oligonucleotide Targeting Apolipoprotein B
Tejdip Singh, M.D., Medical Director, Global Patient Safety and Risk Management, Genzyme Corporation, USA

Oligonucleotide and Delivery Platform Optimization Strategies for siRNA Drug Development

Laura Sepp-Lorenzino, Ph.D.

Laura Sepp-Lorenzino, Ph.D., Senior Director, RNA Therapeutics, Merck & Co., Inc., USA

Recent Advances in Routes of Delivery for Peptide Pharmaceuticals

Nozer Mehta, Ph.D.

Nozer Mehta, Ph.D., Vice President, R&D, UniGene Laboratories, Inc., USA

Overview of Peptide Therapeutics and Vaccines in Development

Yuji Heike, M.D., Ph.D.

Yuji Heike, M.D., Ph.D., Chief of Medical Staff, Department of Medical Oncology, National Cancer Center Hospital, Japan

Evolution and Development of GLP-1 Based Therapeutics

Andrew A. Young, M.D., Ph.D.

Andrew A. Young, M.D., Ph.D., Vice President, Head, Enterendocrine Biology, GlaxoSmithKline, USA

A Pivotal Year for Oligonucleotide Therapeutics

Arthur A. Levin, Ph.D.

Arthur A. Levin, Ph.D., Chief Development Officer, Santaris A/S, USA and Denmark

RaPID Selection of a New Class of Peptide Drug Leads against Various Therapeutic Targets

Hiroaki Suga, Ph.D.

Hiroaki Suga, Ph.D., Professor, Chemical Biology and Biotechnology Lab, The University of Tokyo, Japan

200名を超える科学者やビジネスパーソンが2011年3月2〜4日に東京で開催されたAsiaTIDES 2011に参加し、交流を図りました。AsiaTIDESは、オリゴヌクレオチドやペプチドをベースとした治療薬に関する最新の研究動向や製造技術について学ぶイベントです。世界各国のプレゼンターがこのカンファレンスで最新動向について報告しました。AsiaTIDESは日本で他に類をみないプログラム内容となっています。

カンファレンスでは、デリバリー技術、マイクロRNA、RNAi、ペプチドおよびオリゴの製造・分析の最新動向に焦点を当て、Oligo Safety Working Groupや、AsiaTIDESの直前に開催されたJPMA会議からのレポートを含め、法規制に関するレポートをお伝えします。参加者の皆様は、バイオ分析技術に関する詳細なスキルと、治験薬登録に向けたオリゴまたはペプチド薬剤の開発方法について詳しく学ぶことができます。

ご好評をいただいた基調講演：

Pieter R. Cullis, Ph.D.

Design of Lipid Nanoparticle Systems for the Systemic Delivery of siRNA
Pieter Cullis, Ph.D., FRSC
Professor, Biochemistry; Director, Nanomedicine Research Group
University of British Columbia, Canada

Kazunori Kataoka, Ph.D.

Supramolecular Structures from Block Copolymers for Nanocarriers in Oligonucleotide Delivery
Kazunori Kataoka, Ph.D.
Professor, Materials Engineering and Center for Disease Biology and Integrated Medicine
University of Tokyo, Japan

Eric Tomlinson, Ph.D., D.Sc.

Transdermal Patch Delivery of Peptide Drugs
Eric Tomlinson, Ph.D., D.Sc.
President and Chief Executive Officer
Altea Therapeutics Corporation, USA

Daphna Heffetz, Ph.D.

Clinical Breakthroughs in Transdermal Delivery of Peptides
Daphna Heffetz, Ph.D.
CEO and Director
TransPharma Medical Ltd, Israel

Tomi K. Sawyer, Ph.D.

Stapled α-Helical Peptides: The Twists and Turns of Drug Discovery
Tomi K. Sawyer, Ph.D.
Senior Vice President and Chief Scientific Officer
Aileron Therapeutics Inc., USA

AsiaTIDES will be held again in March 2012 in Tokyo. Plan now to meet the leading players and access the latest data at AsiaTIDES.